Alivus Life Sciences Limited — Quarterly Results & Earnings

₹972.70

-0.40%

Profit Growth YoY36.41%Latest quarter

Sales Growth YoY16.00%Latest quarter

Sales CAGR 5Y9.20%5 year compound

Profit CAGR 5Y8.92%5 year compound

📋

Quarterly Performance

YoY Profit Growth+36.41%

🔥 Exceptional growth

YoY Sales Growth+16.00%

✅ Strong growth

OPM 5Y Average

Operating profit margin

29.62%

EPS Growth 5Y

-52.37%

Interest Coverage

Higher = safer debt servicing

167.33

ROE

18.69%

ROCE

24.92%

💡

Growth Analysis

Alivus Life Sciences Limited reported YoY profit growth of 36.41% and revenue growth of 16.00% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 9.20% and profits at 8.92% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Alivus Life Sciences Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.